T. B. Dschietzig and G. Salama, “Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378”, Global Cardiol, vol. 2, no. 4, Dec. 2024.